WASHINGTON - Generic versions of the popular Flonase nasal spray for allergies are headed to pharmacies after all. Generic makers Roxane Laboratories and Par Pharmaceuticals announced Tuesday that they had resumed shipments of their fluticasone propionate nasal sprays, after a U.S.

The FDA has approved Roxane Laboratories allergy relief nasal spray, a generic equivalent of GlaxoSmithKline's Flonase spray, causing shares in the UK-based pharmaceutical giant to slip by nearly 1%.

By STEPHEN POUNDS Palm Beach Post Staff Writer Nabi Biopharmaceuticals has filed suit to stop an Ohio-based drug company from selling a generic equivalent for its PhosLo drug for kidney-dialysis patients, the Boca Raton company said Tuesday.

By Stephen Pounds, The Palm Beach Post, Fla. Sep. 28--Nabi Biopharmaceuticals has filed suit to stop an Ohio-based drug company from selling a generic equivalent for its PhosLo drug for kidney-dialysis patients, the Boca Raton company said Tuesday.